Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.0030 USD
Change Today 0.00 / 0.00%
Volume 0.0
TSOI On Other Exchanges
As of 8:10 PM 05/26/15 All times are local (Market data is delayed by at least 15 minutes).

therapeutic solutions intern (TSOI) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/28/15 - $0.0063
52 Week Low
03/30/15 - $0.0011
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

therapeutic solutions intern (TSOI) Related Businessweek News

No Related Businessweek News Found

therapeutic solutions intern (TSOI) Details

Therapeutic Solutions International, Inc. manufactures and sells plastic intraoral devices in the United States and internationally. The company offers Anterior Midpoint Stop Appliances (AMPSA), which are used for the treatment and prevention of common neurological and temporomandibular disorders, including migraine headaches, migraine pain, and bruxism. Therapeutic Solutions International, Inc. sells its products under the AMPSA CS and Migran-X names, as well as under the NTI and NTI-tss names directly to licensed dentists in the United States, as well as to licensed dentists internationally directly and through distributors. It also provides AMPSA-related educational programs. Therapeutic Solutions International, Inc. is based in Oceanside, California.

therapeutic solutions intern (TSOI) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

therapeutic solutions intern (TSOI) Key Developments

Therapeutic Solutions International, Inc. announced delayed annual 10-K filing

On 03/31/2014, Therapeutic Solutions International, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

Therapeutic Solutions International, Inc. Announces the Creation of New Supplement Division Focusing on Direct to Consumer Sales

Therapeutic Solutions International, Inc. announced the creation of a new supplement division focusing on Direct to Consumer sales. The company launching this division online with an initial five products. Three of initial products are T-Rx(TM), a product that naturally increases Testosterone; Vital(TM), a product for the active female; and Noxon 240g(TM), a pre-workout Nitric Oxide (NO) product. The company to add additional products in the future.

Therapeutic Solutions International, Inc. Announces Agreement with Quture International, Inc. for QualVal Services Implementing QualOptima Analytics

Therapeutic Solutions International, Inc. announced an agreement with Quture International, Inc. to implement QualOptima analytics software as a service (SaaS) for TSI.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TSOI:US $0.00 USD 0.00

TSOI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TSOI.
View Industry Companies

Industry Analysis


Industry Average

Valuation TSOI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.3x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THERAPEUTIC SOLUTIONS INTERN, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at